An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed
Clinical trial NCT00497770 · COMPLETED
Trial details
- NCT number
- NCT00497770
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2007-02-01
- Primary completion
- 2011-03-01
- Enrollment
- 434
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.